Phosphoribosyl pyrophosphate aminotransferase (PPAT) is a key regulatory enzyme in de novo purine nucleotide biosynthesis and has become an attractive and credible drug target for leukemia and other cancer therapeutics (35, 36), but its function in HCC remains unclear. The gene discussed is PPAT; the disease is hepatocellular carcinoma.